Dermatologist vs. General Practitioner: When to See a Specialist

Skin complaints account for a substantial share of primary care visits in the United States, yet not every skin condition requires the same level of clinical expertise to diagnose and manage. This page examines the structural differences between a general practitioner (GP) and a board-certified dermatologist, outlines the conditions each provider type is equipped to handle, and maps the decision boundaries that guide appropriate referral. Understanding those boundaries reduces diagnostic delay and improves outcomes for conditions ranging from persistent acne to early-stage melanoma.

Definition and Scope

A general practitioner — also referred to as a primary care physician (PCP), family medicine physician, or internist — is trained across a broad spectrum of organ systems and disease categories. Dermatology comprises a fraction of that training: the Liaison Committee on Medical Education (LCME), which accredits U.S. medical schools, does not mandate a minimum number of dermatology-specific clinical hours, and a 2014 analysis published in the Journal of the American Academy of Dermatology found that U.S. medical students received a median of 14 days of dermatology instruction during their entire undergraduate medical education.

A dermatologist, by contrast, completes a dedicated 3-year accredited residency in dermatology following internship, as governed by the Accreditation Council for Graduate Medical Education (ACGME). Board certification is awarded by the American Board of Dermatology (ABD) following successful passage of written and, in most pathways, procedural examinations. The scope of dermatology encompasses over 3,000 distinct skin, hair, and nail conditions (American Academy of Dermatology, AAD).

The skin conditions overview on this site provides a structured taxonomy of those conditions, which helps contextualize why specialty training carries clinical weight. For the regulatory and licensing framework governing both provider types, the regulatory context for dermatology page details the relevant state medical board structures and federal oversight mechanisms.

How It Works

The Primary Care Entry Point

Most insurance structures in the United States — including the majority of Health Maintenance Organization (HMO) plans governed by state insurance commissioners and, in federal programs, the Centers for Medicare & Medicaid Services (CMS) coverage rules — route patients through a PCP before authorizing specialist referrals. This gatekeeping function is not arbitrary: it preserves specialist capacity for complex cases and reduces redundant specialist visits for self-limiting conditions.

A GP encountering a skin complaint will typically follow a structured workflow:

1. Visual assessment and history-taking — duration, progression, associated symptoms, medication history, family history of skin disease.
2. Differential diagnosis construction — the GP generates a short list of probable diagnoses using pattern recognition trained across all organ systems.
3. Empirical treatment trial — for conditions with high prior probability and low diagnostic ambiguity (e.g., mild tinea corporis, seborrheic dermatitis), the GP may prescribe treatment without specialist input.
4. Referral decision — if the condition does not respond to first-line treatment, carries diagnostic uncertainty, involves a potentially malignant lesion, or requires a procedure outside GP scope (e.g., skin biopsy, patch testing, or Mohs surgery), a referral to dermatology is initiated.

The Dermatology Specialist Visit

Dermatologists bring diagnostic tools and procedural competencies unavailable in most primary care settings. These include dermoscopy (dermoscopy and skin imaging), patch testing for contact allergens, in-office cryotherapy, and surgical excision with histopathologic correlation. The dermatologist also has access to a broader pharmacologic armamentarium, including biologics approved by the U.S. Food and Drug Administration (FDA) for conditions such as moderate-to-severe psoriasis and atopic dermatitis — agents that require baseline laboratory monitoring and ongoing safety surveillance outside typical GP workflows.

Common Scenarios

The following categories represent the clearest clinical demarcations between GP-appropriate management and dermatology referral.

Conditions Frequently Managed by a GP

• Mild-to-moderate acne — first-line topical regimens (benzoyl peroxide, topical retinoids, topical antibiotics) fall within GP prescribing competency; see acne causes and treatment for clinical detail.
• Uncomplicated tinea infections — superficial fungal skin infections with classic morphology respond predictably to topical antifungals.
• Minor contact dermatitis — acute, localized reactions with an identifiable trigger and no systemic involvement.
• Seborrheic dermatitis — a chronic but typically straightforward condition manageable with OTC or prescription antifungal shampoos and low-potency topical corticosteroids.
• Simple warts — common verrucae without widespread distribution or immunocompromised host status.

Conditions That Warrant Dermatology Referral

• Atopic dermatitis — moderate-to-severe eczema and atopic dermatitis that has failed 2 or more topical treatment courses, or any case requiring biologic therapy (e.g., dupilumab, tralokinumab).
• Psoriasis — psoriasis types and management encompass variants (pustular, erythrodermic, nail) requiring specialist oversight; systemic and biologic agents carry FDA-mandated Risk Evaluation and Mitigation Strategy (REMS) requirements in some cases.
• Suspected skin malignancy — any pigmented lesion with ABCDE features (Asymmetry, Border irregularity, Color variation, Diameter >6 mm, Evolution), as detailed under melanoma recognition and risk and skin cancer types and warning signs.
• Rosacea with ocular involvement or treatment resistance — rosacea diagnosis and care notes that ocular rosacea carries corneal complication risk requiring coordinated care.
• Hair loss with diagnostic ambiguity — alopecia and hair loss includes scarring alopecias that require scalp biopsy for definitive classification.
• Vitiligo — phototherapy and emerging JAK-inhibitor therapies for vitiligo fall outside routine GP scope.

Decision Boundaries

Three structural criteria govern whether a skin complaint crosses from GP-manageable to specialist-required territory:

1. Diagnostic Certainty

A GP should refer when the lesion or eruption lacks a confident diagnosis after clinical assessment. Diagnostic uncertainty in dermatology carries specific risk because malignant and benign lesions can be morphologically similar on visual inspection alone. The AAD's clinical practice guidelines note that dermoscopy improves melanoma detection sensitivity by approximately 49% compared to naked-eye examination alone — a tool routinely available to dermatologists but rarely deployed in primary care.

2. Treatment Response Failure

The standard threshold across most dermatology subspecialty referral guidelines — including those referenced by the National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) — is failure of 2 adequate treatment trials at appropriate dosing duration before escalating to specialist care.

3. Procedural Requirement

Certain diagnostic and therapeutic procedures are outside GP scope by training and, in most U.S. states, by the practical limits of office infrastructure:

• Shave biopsy, punch biopsy, or excisional biopsy with margin assessment
• Mohs micrographic surgery
• Narrowband UVB or PUVA phototherapy
• Intralesional injections for alopecia areata or hypertrophic scarring
• Allergen-specific patch testing panels

GP vs. Dermatologist: Structural Comparison

For patients seeking a specialist, the finding a dermatologist in the US page covers credentialing verification, board certification lookup through the ABD, and insurance network navigation. The home page provides an orientation to the full range of dermatologic topics covered across this resource.

Occupational exposures represent a distinct referral trigger: workers in industries with sustained chemical, UV, or physical skin exposure — categories tracked by the Occupational Safety and Health Administration (OSHA) under 29 CFR Part 1910 — carry elevated risk for contact dermatitis and occupational skin cancers warranting specialist evaluation independent of symptom severity. See occupational skin conditions for condition-specific detail.

Pediatric dermatology represents a further subspecialty boundary: conditions such as epidermolysis bullosa, ichthyoses, and extensive infantile heman

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)